DIRUI Presents Innovative IVD Solutions at ADLM 2024 Chicago

Date of publication：2024-08-05 00:18:24

On July 30, ADLM 2024 Clinical Lab Expo (formerly known as AACC Clinical Lab Expo), the world's largest exposition of clinical laboratory products and services, kicked off at the McCormick Place Exhibition Centre in Chicago, attracting more than 900 exhibitors and 70,000 industry professionals from around the world. As one of the leading IVD companies in China, DIRUI exhibited innovative diagnostic solutions in booth 3806.

For DIRUI’s significant contribution and generous support to ADLM, this year, DIRUI received 2024 Top Corporate Supporter Award from the association.

At ADLM 2024 Clinical Lab Expo, DIRUI featured the innovative solutions of

Urinalysis

Delivering increased efficiency to streamline urinalysis workflow by leveraging proprietary flow imaging technique

MUS-3600, having a flexible combination of modules and a throughput of 480 tests/hour(for hybrid), up to 520 urine samples can be loaded at one time

FUS-1000, a urinalysis hybrid with a throughput of 60 tests/hour for both chemistry and and formed element

HC-300, compact design, maximum throughput 120 tests/hour

Clinical Chemistry

Providing complete, cost-effective solutions for clinical laboratories' testing

CS-T240Plus, powerful desktop analyzer with a maximum throughput of 240 tests/hour at a constant speed and 480 tests/hour with ISE

Clinical Chemistry & Immunoassay

Combining the required flexibility, scalability with an extensive assay menu to meet the needs of different laboratories

CSM-8000, an integrated chemistry-immunoassay system with ultra-high throughout for chemistry 2,000 tests/hour, immunoassay 320 tests/hour

Hematology

Helping laboratories to perform complete blood counts, blood cell differentials and analysis

BF-7200Plus, configured with BSP-800 Slide Maker/Stainer, offering measurement of 37 parameters(including RET detection), five scattergrams and two histograms, maximum throughput 480 tests/hour

During the event, Feng Yi, Director of CR Capital Management and Chief Strategy Officer of DIRUI, and Niu Dandan, Vice President of DIRUI and General Manager of DIRUI International Marketing Centre, led our international team to discuss our extensive product portfolio with visitors on site, explaining our product features and sharing our innovations for laboratory diagnostics from the customer's perspective. Through our enthusiastic and professional presentations, DIRUI won high praise and recognition from many clinicians, medical professionals and distributors.

With the ever-changing needs of the healthcare system, laboratory operations and efficiency are expected to be optimized while improving patient care. By sticking to the mission of “To Popularize Diagnostics and Benefit the Masses”, DIRUI is committed to providing innovative solutions to simplify and streamline testing for laboratories of all sizes. DIRUI also looks forward to working with our global partners to create more value and inject new momentum into the development of the global in vitro diagnostic industry.

To find out more about our insights into the future diagnostics, please visit

www.en.dirui.com.cn

Last article：Overseas Engineers’ Training at DIRUI Headquarter (July 2024) Next articleDIRUI Joins IFCC as Corporate Member

Dirui News